170 related articles for article (PubMed ID: 28472944)
1. Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study.
Wu CW; Wu JY; Lee MG; Lai CC; Wu IL; Tsai YW; Chang SS; Lee CC
BMC Pulm Med; 2017 May; 17(1):82. PubMed ID: 28472944
[TBL] [Abstract][Full Text] [Related]
2. Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from Taiwan.
Chen YJ; Wu CY; Shen JL; Chen TT; Chang YT
J Am Acad Dermatol; 2013 Jul; 69(1):25-33. PubMed ID: 23375515
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
4. Risk of incident active tuberculosis and use of corticosteroids.
Lai CC; Lee MT; Lee SH; Lee SH; Chang SS; Lee CC
Int J Tuberc Lung Dis; 2015 Aug; 19(8):936-42. PubMed ID: 26162360
[TBL] [Abstract][Full Text] [Related]
5. Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence.
Shau WY; Chen HC; Chen ST; Chou HW; Chang CH; Kuo CW; Lai MS
BMC Cardiovasc Disord; 2012 Feb; 12():4. PubMed ID: 22297085
[TBL] [Abstract][Full Text] [Related]
6. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
8. Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.
Schmidt M; Christiansen CF; Mehnert F; Rothman KJ; Sørensen HT
BMJ; 2011 Jul; 343():d3450. PubMed ID: 21727167
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs, renin-angiotensin system blockade or diuretics and risk of acute kidney injury: A case-crossover study.
Weng SE; Hsu WT; Hsiao FY; Lee CM
Arch Gerontol Geriatr; 2024 Aug; 123():105394. PubMed ID: 38537386
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study.
Wu JY; Lee MG; Lee SH; Lee SH; Tsai YW; Hsu SC; Chang SS; Lee CC
Medicine (Baltimore); 2016 May; 95(19):e3579. PubMed ID: 27175655
[TBL] [Abstract][Full Text] [Related]
11. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan.
Chang CH; Chen HC; Lin JW; Kuo CW; Shau WY; Lai MS
Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):763-71. PubMed ID: 21618340
[TBL] [Abstract][Full Text] [Related]
12. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population.
García Rodríguez LA; Barreales Tolosa L
Gastroenterology; 2007 Feb; 132(2):498-506. PubMed ID: 17258728
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal Anti-Inflammatory Drugs and Risk of First Hospitalization for Heart Failure in Patients with No History of Heart Failure: A Population-Based Case-Crossover Study.
Huang SP; Wen YC; Huang ST; Lin CW; Wang TD; Hsiao FY
Drug Saf; 2019 Jan; 42(1):67-75. PubMed ID: 30232741
[TBL] [Abstract][Full Text] [Related]
14. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of incident osteoporosis and osteoporotic fracture in tuberculosis patients: a population-based study in a tuberculosis-endemic area.
Chen YY; Feng JY; Ting WY; Yen YF; Chuang PH; Pan SW; Su VY; Su WJ
Osteoporos Int; 2017 May; 28(5):1711-1721. PubMed ID: 28331966
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs use and risk of upper gastrointestinal adverse events in cirrhotic patients.
Lee YC; Chang CH; Lin JW; Chen HC; Lin MS; Lai MS
Liver Int; 2012 May; 32(5):859-66. PubMed ID: 22226322
[TBL] [Abstract][Full Text] [Related]
19. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.
Gunter BR; Butler KA; Wallace RL; Smith SM; Harirforoosh S
J Clin Pharm Ther; 2017 Feb; 42(1):27-38. PubMed ID: 28019014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
